Drug Master Files for: DALFAMPRIDINE
✉ Email this page to a colleague
DALFAMPRIDINE Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
17860 | A | II | 11/29/2004 | CU CHEMIE UETIKON GMBH | DALFAMPRIDINE |
24718 | A | II | 3/21/2011 | JUBILANT GENERICS LTD | DALFAMPRIDINE USP |
25695 | I | II | 5/15/2012 | ENALTEC LABS PRIVATE LTD | DALFAMPRIDINE |
27623 | A | II | 10/18/2013 | INDUSTRIALE CHIMICA SRL | DALFAMPRIDINE |
27637 | A | II | 11/1/2013 | ALKEM LABORATORIES LTD | DALFAMPRIDINE USP |
27647 | A | II | 10/15/2013 | PROCOS SPA | DALFAMPRIDINE |
27662 | A | II | 11/18/2013 | SUN PHARMACEUTICAL INDUSTRIES LTD | DALFAMPRIDINE USP |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information